Parkman Healthcare Partners’s AbbVie ABBV Stock Holding History

Parkman Healthcare Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.3M	Buy	+75,000	New	+$16.6M	1.68%	19
2022 Q2	–	Sell	-45,731	Closed	-$7.41M	–	77
2022 Q1	$7.41M	Sell	45,731 -5,991	-12%	-$870K	2.17%	18
2021 Q4	$7M	Sell	51,722 -23,278	-31%	-$2.75M	1.55%	26
2021 Q3	$8.09M	Buy	+75,000	New	+$8.57M	2.05%	19
2021 Q1	–	Sell	-30,000	Closed	-$3.21M	–	84
2020 Q4	$3.21M	Sell	30,000 -45,008	-60%	-$4.33M	0.82%	49
2020 Q3	$6.57M	Buy	75,008 +8	+0%	+$753	1.74%	20
2020 Q2	$7.36M	Buy	+75,000	New	+$6.6M	2.07%	16

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkman Healthcare Partners's ABBV Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in AbbVie (ABBV) in Q1 2026: 75,000 shares worth $16.3M. The stake represents 1.68% of the portfolio and ranks #19 among its holdings. This is a return to the name: Parkman Healthcare Partners previously reported a position in ABBV as recently as Q1 2022.

Parkman Healthcare Partners first reported a position in ABBV in Q2 2020 and has held it in 7 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Parkman Healthcare Partners held 75,000 shares of AbbVie worth $16.3M as of Q1 2026.
AbbVie was a new Parkman Healthcare Partners position in Q1 2026.
AbbVie made up 1.68% of Parkman Healthcare Partners's portfolio in Q1 2026, its #19 holding.
Parkman Healthcare Partners first reported a position in AbbVie in Q2 2020 and has held it in 7 quarters since.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.